Default company panoramic image
Dbac4663 a9bc 48c3 bf31 4369542ccc5a

Xcede Technologies

Xcede Technologies will develop & market a high strength, fast-acting, combination hemostat/sealant device with broad surgical indication.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Rochester, MN, USA
  • Currency USD

Company Summary

Xcede Technologies, based in Rochester, MN, began operations this year following a technology transfer from Dynasil Biomedical. Xcede is committed to the development and manufacturing of innovative hemostatic (bleeding prevention) and sealant products for surgical application. Our first product is a resorbable hemostatic bandage to be used when conventional techniques are inadequate or impractical during general or cardiovascular surgery.


  • Default avatar
    Allen Berning

    Mr. Berning is an entrepreneur with over 20 years of experience managing technology start-ups. Mr. Berning was the CEO of Hardcore Computer from 2007 to 2012. Prior to Hardcore Computer Mr. Berning was CEO and Chairman of the Board of PEMSTAR from its founding in 1994. Mr. Berning led PEMSTAR to an IPO on NASDAQ in 2000 and its merger with Benchmark Electronics. In the early part of his career, Mr. Berning held numerous positions in management an

  • Default avatar
    Daniel Ericson Ph.D.
    Chief Technical Officer

    Dr. Ericson joined Dynasil Biomedical in April 2011 as the VP of Scientific Development. Prior to Dynasil Biomedical, he was the founder and President of SUBC Cardiovascular, an early stage research and development company, which successfully prototyped and licensed multiple technologies to Boston Scientific, Medtronic, Viacell and others. Early in his career he worked as a consultant to 3M Biosciences and Avecor Vascular. Dr. Ericson has his Ph.

  • Default avatar
    Bradley Poff, DVM
    Senior Vice President, Clinical & Regulatory

    Dr. Poff has over 25 years of experience in clinical and preclinical research. Prior to working with Dynasil Biomedical, Dr. Poff was cofounder and General Manager for Augmenix, Inc., a start-up medical device company. Prior to Augmenix, he was VP of Preclinical Sciences at Boston Scientific and Sr. Director of Clinical Research at Genzyme Corporation. Prior to Genzyme Dr. Poff was the Sr. Director Preclinical and Clinical Research for Focal, Inc

  • Default avatar
    Kyle Brandy
    Senior Scientist

    Mr. Brandy joined Dynasil Biomedical in November 2011 as a Senior Scientist. Prior to Dynasil Biomedical Mr. Brandy worked at the University of Minnesota in biochemistry research. Prior to working at the University Mr. Brandy worked for SUBC Cardiovascular. Mr. Brandy has an M.S. and B.S. in Biochemistry from the University of Minnesota.